Your browser doesn't support javascript.
loading
Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Sheng, Jindan; Kohno, Susumu; Okada, Nobuhiro; Okahashi, Nobuyuki; Teranishi, Kana; Matsuda, Fumio; Shimizu, Hiroshi; Linn, Paing; Nagatani, Naoko; Yamamura, Minako; Harada, Kenichi; Horike, Shin-Ichi; Inoue, Hiroshi; Yano, Seiji; Kumar, Sharad; Kitajima, Shunsuke; Ajioka, Itsuki; Takahashi, Chiaki.
Affiliation
  • Sheng J; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Kohno S; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Okada N; Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan.
  • Okahashi N; Graduate School of Information Science and Technology, Osaka University, Suita, Japan.
  • Teranishi K; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Matsuda F; Graduate School of Information Science and Technology, Osaka University, Suita, Japan.
  • Shimizu H; Graduate School of Information Science and Technology, Osaka University, Suita, Japan.
  • Linn P; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Nagatani N; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Yamamura M; Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Harada K; Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Horike SI; Advanced Science Research Center, Kanazawa University, Kanazawa, Japan.
  • Inoue H; Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
  • Yano S; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Kumar S; Centre for Cancer Biology, University of South Australia, Adelaide, SA, Australia.
  • Kitajima S; Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Ajioka I; Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahashi C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Hepatology ; 74(4): 1971-1993, 2021 10.
Article in En | MEDLINE | ID: mdl-33931882

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Carcinoma, Hepatocellular / Protein Kinase Inhibitors / Cell Proliferation / Liver Neoplasms Limits: Animals / Humans Language: En Journal: Hepatology Year: 2021 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Carcinoma, Hepatocellular / Protein Kinase Inhibitors / Cell Proliferation / Liver Neoplasms Limits: Animals / Humans Language: En Journal: Hepatology Year: 2021 Document type: Article Affiliation country: Japón